Position in ABBV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,104,281,370
-$115,909,298 QoQ
Shares Held
4,388,338
-21.8% QoQ
Ownership
0.248%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#43
of 4,150 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 74%
Shared 24%
None 2%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $6,486,971,678 across 12 Drug Manufacturers - General names. ABBV ranks #3 (17.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,539,098 | $2,676,614,716 | |
| 2 | PFE |
Pfizer Inc
|
56,551,011 | $1,361,748,341 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
4,388,338 | $1,104,281,370 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
6,651,833 | $840,392,576 | |
| 5 | LLY |
ELI LILLY & Co
|
145,790 | $174,864,912 | |
| 6 | BIIB |
Biogen Inc.
|
744,892 | $160,941,363 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
948,427 | $54,648,359 | |
| 8 | NVS |
Novartis AG
|
293,443 | $45,988,386 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,104,281,370 | 4,388,338 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $1,220,190,668 | 5,610,330 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,499,867,306 | 6,564,258 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $1,935,995,541 | 8,361,387 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,600,113,260 | 8,620,371 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,854,303,538 | 8,850,246 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $1,607,866,557 | 9,048,208 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,842,642,234 | 9,330,779 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,536,300,692 | 8,956,977 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,581,274,087 | 8,683,548 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,305,252,333 | 8,422,613 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $899,185,665 | 6,032,374 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,707,128 | 20,093 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $4,533,437 | 28,446 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,709,390 | 16,765 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,209,230 | 16,461 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $4,378,996 | 28,591 | Shares | Sole | 2022-08-09 | |
| 2021-12-31 | $2,853,284 | 21,073 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,497,423 | 41,693 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $4,610,917 | 40,935 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,597,076 | 42,479 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $5,677,985 | 52,991 | Shares | Sole | 2021-05-12 | |
| 2020-09-30 | $20,713,544 | 236,483 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $33,527,585 | 341,491 | Shares | Sole | 2020-11-20 | |
| 2020-03-31 | $21,422,570 | 281,173 | Shares | Sole | 2020-11-20 | |
| No filing history on record for this holder in this stock. | ||||||